Stanley T. Anderson

Oral beta-adrenergic blockade with metoprolol in chronic severe dilated cardiomyopathy

A double-blind crossover trial was performed to assess the effect of metoprolol in 10 patients (mean age 55 years) with severe dilated cardiomyopathy. All patients clinically had idiopathic dilated cardiomyopathy; however, at coronary angiography, four had occult coronary disease. All were in New York Heart Association functional class III with a left ventricular ejection fraction less than 35% as assessed by rest radionuclide ventriculography. Studies were performed before treatment, after 4 weeks of metoprolol therapy and after 4 weeks of placebo administration. Erect bicycle sprint exercise was used to determine maximal work load. Hemodynamic variables and radionuclide left ventricular ejection fraction were recorded at rest and during graded supine bicycle exercise. Cardiac medications were unchanged throughout the trial. The mean (+/- standard error of the mean) dose of metoprolol was 130 +/- 13 mg/day. Metoprolol did not change symptoms, chest X-ray findings or exercise tolerance (baseline 700 +/- 73, placebo 690 +/- 85, metoprolol 710 +/- 81 kilopond-meters [kpm]/min). Metoprolol produced a significant decrease in heart rate at rest and during exercise (p less than 0.001). Mean blood pressure and left ventricular filling pressure did not differ significantly in the baseline, placebo and metoprolol studies. There was a slight, but significant (p less than 0.05) decrease in cardiac index with metoprolol compared with placebo and baseline studies. The small, but significant increase in left ventricular ejection fraction from baseline to the metoprolol and placebo studies (p less than 0.001) was considered a result of spontaneous improvement rather than of therapy. No significant differences were found between the patients with and without coronary disease.(ABSTRACT TRUNCATED AT 250 WORDS)

An electrocardiographic acuteness score for quantifying the timing of a myocardial infarction to guide decisions regarding reperfusion therapy.

Abstract The method of determining the acuteness score presented in the present study is suggested for use in automated electrocardiographic analysis systems. A potential use of the acuteness score is in combination with historical timing as a guideline for decisions regarding thrombolytic therapy. Patients with an acuteness score above a certain threshold and a brief time from symptom onset may benefit most from thrombolytic therapy. The relation between the levels of acuteness score and the quantity of myocardium salvaged was not determined in the present study because no measure of salvage was available in this population. A future study is suggested in which this relation is determined. An additional use of the acuteness score may be to assess myocardial reperfusion and salvage by examining the time course of progression in score between the ECGs before and sequentially after administration of thrombolytic therapy.

T wave amplitudes in normal populations: Variation with ECG lead, sex, and age

Consideration of increased T wave amplitude (tall T waves), either alone or in association with other electrocardiographic (ECG) parameters, may be beneficial for the early detection of acute transmural ischemia, and quantification of the increase might be used in quantifying the ischemic area. The primary purpose of this study was to quantify normal T wave amplitude limits according to ECG lead, sex, and age. One thousand nine hundred thirty-five subjects in two normal populations were analyzed, and the 98th percentile of the positive T wave amplitude for each ECG lead (including -aVR) was considered the upper limit of normal. Normal T wave amplitude was two times greater in the precordial than in the limb leads, and it was approximately 25% greater in men than in women in all leads. There was approximately a 10% decrease in normal T wave amplitude between 18-39- and 40-59-year-old patients and a 15% decrease between 40-59- and 60-79-year-old patients. The upper limit of normal T wave amplitudes identified in this study confirm those developed by Lepeschkin for use as means for each lead when age and sex are not considered. These limits might be incorporated into both normograms and automated ECG analysis systems to determine the presence or absence of tall T waves in patients presenting with symptoms of acute transmural ischemia.

Panoramic display of the orderly sequenced 12-lead ECG

The standard 12-lead electrocardiogram (ECG) has been developed over many years. The ECG has had a long and successful history of providing diagnostic information in clinical medicine. Cardiac arrhythmias have been elucidated by deductive reasoning from continuous ECG recordings with confirmation from electrophysiologic studies. Recently, there has been renewed interest in the morphology of the QRS complex, ST-segment, and T wave, which raises the important question of considering whether the usual method of display provides maximal diagnostic capabilities. The conventional display provides a logical visualization of precordial lead recordings representing the horizontal plane, but does not provide a logical visualization of the limb lead recordings representing the frontal plane. Many clinical problems require the consideration of serial ECGs necessitating the comparison of separate pages. An alternate format presenting serial recordings on a single page would be advantageous. Some automated ECG analysis systems already include the capability for multiple display formats, but these have not yet been widely used in clinical practice. This point of view paper introduces a new display format for the standard 12-lead ECG that includes: (1) a presentation of an orderly sequence of leads to facilitate scanning through different points in space and (2) a presentation of recordings of 12-lead sequences to facilitate scanning through different points in time. This display format could either replace or supplement the conventional ECG format.

Transvenous, Transmediastinal, and Transthoracic Ventricular Pacing: A Comparison after Complete Two-Year Follow-up

Two hundred and five patients who received a total of 247 electrode systems-129 transvenous, 68 transmediastinal and 50 transthoracic-are compared after complete uniform two-year follow-up. The transvenous patients had low hospital morbidity (19%) and short hospital stays (75% ≤ 8 days) but a high incidence of electrode failure by 24 months (38%). The transmediastinal and transthoracic patients had more hospital complications (35% and 34%) and longer periods of hospitalization (57% and 70% > 8 days) but fewer instances of failure by 24 months (16% and 11%). Most transvenous electrode failures were secondary to dislodgement. Transmediastinal right epicardial electrodes had the unique problem of threshold elevation and failure between six and 12 months after implantation as well as a high incidence of sudden death in this same period. Although the high incidence of endocardial electrode instability dictates the need for an alternative approach to permanent pacing, the failure of the transmediastinal approach to significantly alter postoperative morbidity (as compared with transthoracic electrodes) and the incidence of threshold elevation remote from right ventricular implantation suggest that limitation of thoracotomy (via the transmediastinal approach) should not take precedence over left ventricular implantation. Development of electrodes which would provide more permanent low resistance fixation to right ventricular endocardium or epicardium may be necessary before the transthoracic approach can be abandoned.

Combined historical and electrocardiographic timing of acute anterior and inferior myocardial infarcts for prediction of reperfusion acheivable size limitation

The historical time of acute symptom onset is not always an accurate indication of the timing of onset of an acute myocardial infarction (AMI). Consideration of electrocardiographic (ECG) timing parameters could supplement historical timing alone as a clinical guide for decisions regarding the use of reperfusion therapy. Three hundred ninety-five patients from 4 trials of thrombolytic therapy conducted in the northwestern United States and western Canada are included in the present study. A total of 316 patients received either streptokinase or tissue plasminogen activator, and 79 received no reperfusion therapy. Historical time of symptom onset was acquired by emergency or cardiology department personnel and recorded on patient report forms. An ECG method for estimating the timing of the AMI, the Anderson-Wilkins (AW) acuteness score, was calculated from the initial standard 12-lead recording by investigators blinded to the knowledge of symptom duration or any other study variables. Tomographic thallium-201 imaging 7 weeks after hospital admission was used to measure final AMI size. The ECG timing method achieved a relation with final AMI size similar to that previously reported for historical timing. The AW acuteness score proved most useful for anterior AMI location when there was a > or = 2 hour delay following symptom onset, but was most useful for the inferior AMI location when there was a < 2 hour delay. Despite a longer delay, patients with high AW acuteness scores had 50% lower final anterior AMI size than those with low scores; and despite a shorter delay, those with low ECG acuteness scores had 50% greater final inferior AMI size than those with high scores. The AW acuteness score combined with the historical estimation of symptom duration should provide a more accurate basis for predicting the potential for limitation of final AMI size than either method alone. These results could potentially provide the basis for developing a new method for noninvasive guidance of clinical decisions regarding administration of reperfusion therapy in the initial evaluation of patients with AMI.

Incremental value of clinical assessment, supine exercise electrocardiography, and biplane exercise radionuclide ventriculography in the prediction of coronary artery disease in men with chest pain

The incremental value of clinical assessment, exercise electrocardiography (ECG) and biplane radionuclide ventriculography (RVG) in the prediction of coronary artery disease (CAD) was assessed in 105 men without myocardial infarction who were undergoing coronary angiography for investigation of chest pain. Independent clinical assessment of chest pain was made prospectively by 2 physicians. Graded supine bicycle exercise testing was symptom-limited. Right anterior oblique ECG-gated first-pass RVG and left anterior oblique ECG-gated equilibrium RVG were performed at rest and exercise. Regional wall motion abnormalities were defined by agreement of 2 of 3 blinded observers. A combined strongly positive exercise ECG response was defined as greater than or equal to 2 mm ST depression or 1.0 to 1.9 mm ST depression with exercise-induced chest pain. A multivariate logistic regression model for the preexercise prediction of CAD was derived from the clinical data and selected 2 variables: chest pain class and cholesterol level. A second model assessed the incremental value of the exercise test in prediction of CAD and found 2 exercise variables that improved prediction: RVG wall motion abnormalities, and a combined strongly positive ECG response. Applying the derived predictive models, 37 of the 58 patients (64%) with preexercise probabilities of 10 to 90% crossed either below the 10% probability threshold or above the 90% threshold and 28 (48%) also moved across the 5 and 95% thresholds. Supine exercise testing with ECG and biplane RVG together, but neither test alone, effectively adds to clinical prediction of CAD. It is most useful in men with atypical chest pain and when the ECG and RVG results are concordant.

Radionuclide angiographic assessment of global and segmental left ventricular function at rest and during exercise after coronary artery bypass graft surgery.

Left ventricular ejection fraction (LVEF) was measured by radionuclide angiography at rest and during supine bicycle exercise before and 3 months after coronary artery bypass graft surgery (CABG) in 20 patients with chronic stable angina. The right anterior oblique gated first-pass technique was used to assess LVEF response to maximal exercise (Wmax), while the left anterior oblique equilibrium-gated technique was used to assess LVEF and relative LV volume changes during graded submaximal exercise. Mean LVEF was unchanged at rest after CABG by both the first-pass (60 12% vs 60 ± 12%) and equilibrium-gated (61 ± 13% vs 62 ± 13%) measurements. At Wmax, mean first-pass LVEF was significantly higher postoperatively than preoperatively (63 ± 17% vs 53 ± 17%; p < 0.01), with a higher Wmax (750 ± 182 vs 590 ± 202 kpm/min; p < 0.001) and higher rate-pressure product (302 ± 59 vs 222 ± 57 units; p < 0.001). Similarly, equilibrium-gated LVEF levels during graded exercise, using stepwise regression analysis, were significantly higher postoperatively than preoperatively (p< 0.001); at the highest graded work load, they averaged 63 ± 19% postoperatively and 53 ± 17% preoperatively, with higher work loads (500 ± 190 vs 417 ± 155; p< 0.05) and higher rate-pressure products (271 ± 55 vs 207 53; p< 0.001). The increase in exercise LVEF after surgery was due to a marked decrease in the ratio, relative to resting values, of counts-based end-systolic volumes during submaximal exercise (preoperative 1.91 ± 1.04; postoperative 1.14 ± 0.46; p< 0.01). The five subjects in whom LVEF decreased significantly during exercise postoperatively all had one or more blocked or stenosed grafts. This study documents, by two independent radionuclide techniques, an improved LVEF during exercise at an increased maximal work capacity and rate-pressure product 3 months after successful CABG.

Pulmonary embolism secondary to anomalies of deep venous system of the leg.

Two cases of recurrent pulmonary emboli secondary to thrombosis in anomalies of the deep veins of the lower limb are presented. In both cases the source of emboli was not evident clinically, and it was only after venography that the venous anomalies were discovered, both being confined to one limb and amenable to surgical intervention. Such anomalies have not previously been reported as sources of venous thromboembolism in adults. The importance of venography in establishing the source of pulmonary emboli, especially when recurrent, is stressed.

Low dose heparin in the prevention of deepvein thromboses in patients with acute myocardial infarction

Abstract Patients with acute myocardial infarction of less than 48 hours duration were randomized into three groups. The “fully anticoagulated” group received heparin by intravenous infusion and warfarin sodium to maintain a whole blood clotting time of 30 to 90 minutes and a prothrombin index of 10% to 35%. The “low dose” heparin group received 500 units by intravenous infusion every 12 hours. The control group received no anticoagulants. The radioactive fibrinogen test was used to diagnose the presence of leg vein thromboses. The control group had an incidence of venous thrombosis of 29.7% compared with 13.9% in the low dose group and 11.3% in the fully anticoagulated group. Patients in the control group who had cardiac failure had a significantly higher incidence of venous thromboses (71.4%) when compared with patients not in failure (20.0%). In the two treatment groups no significant difference was observed in patients with and without cardiac failure. Patients with cardiac failure complicating an acute myocardial infarction have a high incidence of venous thromboses. Anticoagulants significantly reduce this incidence and low dose intravenous heparin is as efficacious as full anticoagulation.